NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Effects of blood collection conditions on ovarian cancer serum markers.

Author(s): Thorpe JD, Duan X, Forrest R, Lowe K, Brown L, Segal E, Nelson B, Anderson GL, McIntosh M, Urban N

Publication: PLoS One, 2007, Vol. 2, Page e1281

PubMed ID: 18060075 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of anesthesia and time of collection with respect to day of surgery on levels of CA 125, prolactin, and Macrophage Migration Inhibitory Factor (MIF) in serum from healthy volunteers and patients with cancer and other conditions.

Conclusion of Paper

Prolactin levels were significantly increased in serum obtained after the administration of anesthesia on the day of surgery, whether from surgical control patients, benign control patients, or cancer patients, compared to levels measured in serum collected 1-39 days prior to surgery or from healthy controls, but CA-125 and MIF concentrations were only significantly affected by patient diagnosis.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of anesthesia and time of collection with respect to day of surgery on levels of CA 125, prolactin, and MIF in serum from healthy volunteers and patients with ovarian, fallopian tube, and peritoneal cancer and other benign and non-neoplastic conditions.

    Summary of Findings:

    Prolactin levels were significantly increased in serum obtained after the administration of anesthesia on the day of surgery, whether from surgical control patients, benign control patients, or cancer patients, compared to levels measured in serum collected 1-39 days prior to surgery or from healthy controls. In contrast, CA 125 levels and MIF concentrations were significantly different between serum from healthy, surgical, or benign control patients and patients with cancer, regardless of whether the specimen was obtained with no anesthesia 1-39 days prior to surgery or after the administration of anesthesia on the day of surgery.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    • Normal
    • Neoplastic - Benign
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Protein Immunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Anesthesia Collected after administration of anesthesia
    Collected with no anesthesia
    Biospecimen Acquisition Time of biospecimen collection On the day of surgery
    1-39 days prior to surgery
    Preaquisition Diagnosis/ patient condition Normal
    Non-neoplastic condition requiring surgery
    Benign condition requiring surgery
    Malignant condition requiring surgery

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...